Canacol’s Q220 results confirm the financial impact of the reduced production and sales in Q2 as previously announced. While sales and production are down c 25% over Q120, the underlying message is that production continues to improve from an April low following the COVID-19 outbreak, while netbacks also improve with additional sales. EBTIDAX and earnings remain strong, further exemplifying the company’s lean operations and majority (c 80%) take-or-pay offtake contracts denominated in US dollars that protect the company from macro fluctuations.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.